Free Newsletter
ISPE conference content highlights supply chain
ISPE is offering content from its conference held earlier this month. Some speakers were recorded and the content is accessible as downloadable webinars. Content was also delivered virtually via live webcasts and live online speaker presentations.
One session, on global supply chain integrity and anti-counterfeiting, brought together industry leaders and FDA regulators to address concerns about maintaining a safe, efficacious drug supply, according to an announcement.
Amgen Vice President Martin VanTrieste, representing the newly formed Rx360 supply chain organization, was a presenter. He discussed geopolitical environmental scanning, a way "to detect, in advance, potential weaknesses in or disruptions to the supply chain that could lead to contamination, adulteration, or counterfeiting," according to a Pharmaceutical Technology magazine blog on the conference.
- see the ISPE selection of conference content
- review our earlier coverage of Rx360
- visit the PharmTech blog
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
